Ouazzani, Houria El. http://orcid.org/0000-0003-1021-7134
Rouillon, Steeve
Venisse, Nicolas
Sifer-Rivière, Lynda
Dupuis, Antoine
Cambien, Guillaume
Ayraud-Thevenot, Sarah
Gourgues, Anne-Sophie
Pierre-Eugène, Pascale
Pierre, Fabrice
Rabouan, Sylvie
Migeot, Virginie
Albouy-Llaty, Marion
,
Funding for this research was provided by:
Fondation de France (784314908)
Article History
Received: 22 September 2020
Accepted: 10 November 2021
First Online: 4 December 2021
Change Date: 29 December 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s13063-021-05957-4
Declarations
:
: The PREVED study is sponsored by the University Hospital of Poitiers (Contact: Véronique FERRAND-RIGALLAUD). The methodological referent obtained informed consent signed by all participants. Pregnant women are free to leave the study at any time. Additional informed consent forms were developed for collection and use of additional data and biological specimens for two ancillary studies, which were also approved: UnorderedList removedThis trial has been approved by Ethics Committee of the University Hospital of Poitiers, France: approval no. 2015-18 RR/MLB/LB and Committee for Personal Protection (CPP) – Ouest III: approval no. 2015-A00031-48 (HPS). It was registered on the Clinical Trials website, ExternalRef removed (NCT03233984).Results will be published in a peer-reviewed journal. This protocol follows SPIRIT guidelines.
: Not applicable.
: The authors declare that they have no competing interests.